SureTrader SPDR Advertisement
Home > Boards > US OTC > Biotechs > Amarantus Bioscience Holdings Inc. (AMBS)

Amarantus BioScience (AMBS) <u>Price Target $2.25 By Fall</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BCNstocks Member Profile
 
Followed By 315
Posts 33,524
Boards Moderated 0
Alias Born 08/28/10
160x600 placeholder
Advertisement
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 8/26/2015 2:36:12 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 8/26/2015 2:33:37 PM
Amarantus Moves Annual Meeting Date Forward to September 2, 2015 "GlobeNewswire Inc." - 8/26/2015 12:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/20/2015 9:35:46 AM
Amarantus Announces Issuance of United States Patent Covering Proprietary Compositions of Matter and Methods of Use for Produ... "GlobeNewswire Inc." - 8/20/2015 8:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/17/2015 4:35:25 PM
Amarantus Reports Second Quarter 2015 Financial Results and Business Overview "GlobeNewswire Inc." - 8/17/2015 8:05:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/14/2015 6:43:03 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 8/7/2015 5:21:43 PM
Amarantus Announces Adjournment of Annual Meeting "GlobeNewswire Inc." - 8/7/2015 5:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2015 4:28:24 PM
Amarantus Announces a New Eltoprazine Publication Confirming the Long-Term Efficacy and Elucidating the Mechanism of Action i... "GlobeNewswire Inc." - 8/5/2015 8:50:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 8/4/2015 4:51:04 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 8/4/2015 6:35:19 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/3/2015 5:30:48 PM
Amarantus Announces Adjournment of Annual Meeting "GlobeNewswire Inc." - 8/3/2015 5:30:00 PM
Amarantus BioScience, U.S. Army and Rutgers University in Partnership to Expand Development of Engineered Skin Substitute (ES... "GlobeNewswire Inc." - 8/3/2015 6:00:00 AM
Amarantus Announces Publication of a Clinical Study of MSPrecise(R) Diagnostic for Identification of Relapsing-Remitting Mult... "GlobeNewswire Inc." - 7/29/2015 7:35:00 AM
AMARANTUS BIOSCIENCE - BUILDING UP THERAPEUTICS ASSETS "InvestorsHub NewsWire" - 7/28/2015 1:15:01 AM
Amarantus Diagnostics Establishes Strategic Advisory Committee "GlobeNewswire Inc." - 7/27/2015 7:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/22/2015 4:16:56 PM
Amarantus Diagnostics Meets Primary and Secondary Endpoints in Blinded, Multi-Center LP-002 Clinical Study for LymPro(R) Bloo... "GlobeNewswire Inc." - 7/22/2015 10:30:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 7/21/2015 5:02:26 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/20/2015 5:13:21 PM
Amarantus Announces First Patient Dosed in Eltoprazine Phase 2b Study for Treatment of Parkinson's Disease Levodopa-Induced D... "GlobeNewswire Inc." - 7/20/2015 7:05:00 AM
BCNstocks   Tuesday, 02/26/13 12:36:25 PM
Re: None
Post # of 117311 
Amarantus BioScience (AMBS) Price Target $2.25 By Fall 2013 Forecasts Biotech News Stock Review:

Amarantus BioScience (AMBS) Price Target $2.25 By Fall 2013 Forecasts Biotech News Stock Review. AMBS has a huge upside, look for this small biotech to take off soon on some very good news that we are hearing. By Fall today's share price will only be a distant memory!


http://biotechnewsstockreview.blogspot.com/2013/01/amarantus-bioscience-ambs-price-target.html



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist